Skip to main content

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Light Treatment Effectiveness (LITE) Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Light Treatment Effectiveness (LITE) Study

Cardiovalve Transfemoral Mitral Valve System

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Cardiovalve Transfemoral Mitral Valve System

Extension Study in Primary Distal Renal Tubular Acidosis

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Extension Study in Primary Distal Renal Tubular Acidosis

CemiplimAb Survivorship Epidemiology

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about CemiplimAb Survivorship Epidemiology

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients With Non-Ischemic Cardiomyopathy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Analysis of Both Sex and Device Specific Factors on Outcomes in Patients With Non-Ischemic Cardiomyopathy

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 218
  • Page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • Page 224
  • Page 225
  • Page 226
  • …
  • Next page Next
  • Last page Last
Subscribe to